Commentary: Proposed drug price caps would stall health care advances
Allowing a state panel to artificially restrain medication costs would lead to a slower pace of innovation and fewer cures. |!| Portland
Allowing a state panel to artificially restrain medication costs would lead to a slower pace of innovation and fewer cures. |!| Portland